{"gao_id": "GAO-20-212", "published": "2020-01-21T12:00:00Z", "released": "2020-01-27T07:00:00Z", "summary": "If drug manufacturers want certain drugs covered by Medicaid, they must participate in both \u201c340B\u201d and Medicaid Drug Rebate programs. The 340B program allows certain hospitals and clinics to buy discounted drugs. The rebate program allows state Medicaid programs to request manufacturer rebates on certain drugs dispensed to their beneficiaries. Drugs that hospitals and clinics buy through 340B can\u2019t also qualify for Medicaid rebates\u2014as that...", "title": "340B Drug Discount Program: Oversight of the Intersection with the Medicaid Drug Rebate Program Needs Improvement", "topics": ["Medicaid", "Beneficiaries", "Compliance oversight", "Pharmacy", "Health care standards", "Auditors", "Health Care", "Managed health care", "Prescription drugs", "Drugs", "Policies and procedures"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-20-212", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-20-212-highlights.pdf"}, {"title": "Full Report (55 pages)", "url": "https://www.gao.gov/assets/gao-20-212.pdf"}, {"title": "Accessible PDF (63 pages)", "url": "https://www.gao.gov/assets/710/706831.pdf"}]}